114 related articles for article (PubMed ID: 22800288)
1. Targeting claudin-4 in human pancreatic cancer.
Kojima T; Kyuno D; Sawada N
Expert Opin Ther Targets; 2012 Sep; 16(9):881-7. PubMed ID: 22800288
[TBL] [Abstract][Full Text] [Related]
2. Effects of Clostridium perfringens enterotoxin via claudin-4 on normal human pancreatic duct epithelial cells and cancer cells.
Yamaguchi H; Kojima T; Ito T; Kyuno D; Kimura Y; Imamura M; Hirata K; Sawada N
Cell Mol Biol Lett; 2011 Sep; 16(3):385-97. PubMed ID: 21573709
[TBL] [Abstract][Full Text] [Related]
3. Regulation of tight junctions in human normal pancreatic duct epithelial cells and cancer cells.
Kojima T; Sawada N
Ann N Y Acad Sci; 2012 Jun; 1257():85-92. PubMed ID: 22671593
[TBL] [Abstract][Full Text] [Related]
4. Protein kinase Cα inhibitor enhances the sensitivity of human pancreatic cancer HPAC cells to Clostridium perfringens enterotoxin via claudin-4.
Kyuno D; Kojima T; Ito T; Yamaguchi H; Tsujiwaki M; Takasawa A; Murata M; Tanaka S; Hirata K; Sawada N
Cell Tissue Res; 2011 Dec; 346(3):369-81. PubMed ID: 22160590
[TBL] [Abstract][Full Text] [Related]
5. Claudin-4-targeted optical imaging detects pancreatic cancer and its precursor lesions.
Neesse A; Hahnenkamp A; Griesmann H; Buchholz M; Hahn SA; Maghnouj A; Fendrich V; Ring J; Sipos B; Tuveson DA; Bremer C; Gress TM; Michl P
Gut; 2013 Jul; 62(7):1034-43. PubMed ID: 22677720
[TBL] [Abstract][Full Text] [Related]
6. Clostridium perfringens enterotoxin as a potential drug for intravesical treatment of bladder cancer.
Gabig TG; Waltzer WC; Whyard T; Romanov V
Biochem Biophys Res Commun; 2016 Sep; 478(2):887-92. PubMed ID: 27520378
[TBL] [Abstract][Full Text] [Related]
7. Cytotoxicity of Clostridium perfringens enterotoxin depends on the conditions of claudin-4 in ovarian carcinoma cells.
Tanaka S; Aoyama T; Ogawa M; Takasawa A; Murata M; Osanai M; Saito T; Sawada N
Exp Cell Res; 2018 Oct; 371(1):278-286. PubMed ID: 30142326
[TBL] [Abstract][Full Text] [Related]
8. Transcriptional regulation of claudin-18 via specific protein kinase C signaling pathways and modification of DNA methylation in human pancreatic cancer cells.
Ito T; Kojima T; Yamaguchi H; Kyuno D; Kimura Y; Imamura M; Takasawa A; Murata M; Tanaka S; Hirata K; Sawada N
J Cell Biochem; 2011 Jul; 112(7):1761-72. PubMed ID: 21381080
[TBL] [Abstract][Full Text] [Related]
9. Tissue distribution and safety evaluation of a claudin-targeting molecule, the C-terminal fragment of Clostridium perfringens enterotoxin.
Li X; Saeki R; Watari A; Yagi K; Kondoh M
Eur J Pharm Sci; 2014 Feb; 52():132-7. PubMed ID: 24231339
[TBL] [Abstract][Full Text] [Related]
10. Transcriptional control of tight junction proteins via a protein kinase C signal pathway in human telomerase reverse transcriptase-transfected human pancreatic duct epithelial cells.
Yamaguchi H; Kojima T; Ito T; Kimura Y; Imamura M; Son S; Koizumi J; Murata M; Nagayama M; Nobuoka T; Tanaka S; Hirata K; Sawada N
Am J Pathol; 2010 Aug; 177(2):698-712. PubMed ID: 20566751
[TBL] [Abstract][Full Text] [Related]
11. Preparation of a claudin-targeting molecule using a C-terminal fragment of Clostridium perfringens enterotoxin.
Ebihara C; Kondoh M; Hasuike N; Harada M; Mizuguchi H; Horiguchi Y; Fujii M; Watanabe Y
J Pharmacol Exp Ther; 2006 Jan; 316(1):255-60. PubMed ID: 16183701
[TBL] [Abstract][Full Text] [Related]
12. Targeting tight junctions during epithelial to mesenchymal transition in human pancreatic cancer.
Kyuno D; Yamaguchi H; Ito T; Kono T; Kimura Y; Imamura M; Konno T; Hirata K; Sawada N; Kojima T
World J Gastroenterol; 2014 Aug; 20(31):10813-24. PubMed ID: 25152584
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of claudin-3 and claudin-4 receptors in uterine serous papillary carcinoma: novel targets for a type-specific therapy using Clostridium perfringens enterotoxin (CPE).
Santin AD; Bellone S; Marizzoni M; Palmieri M; Siegel ER; McKenney JK; Hennings L; Comper F; Bandiera E; Pecorelli S
Cancer; 2007 Apr; 109(7):1312-22. PubMed ID: 17326053
[TBL] [Abstract][Full Text] [Related]
14. Claudin-4: a new target for pancreatic cancer treatment using Clostridium perfringens enterotoxin.
Michl P; Buchholz M; Rolke M; Kunsch S; Löhr M; McClane B; Tsukita S; Leder G; Adler G; Gress TM
Gastroenterology; 2001 Sep; 121(3):678-84. PubMed ID: 11522752
[TBL] [Abstract][Full Text] [Related]
15. A novel tumor-targeted therapy using a claudin-4-targeting molecule.
Saeki R; Kondoh M; Kakutani H; Tsunoda S; Mochizuki Y; Hamakubo T; Tsutsumi Y; Horiguchi Y; Yagi K
Mol Pharmacol; 2009 Oct; 76(4):918-26. PubMed ID: 19638534
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of Clostridium perfringens enterotoxin receptors claudin-3 and claudin-4 in uterine carcinosarcomas.
Santin AD; Bellone S; Siegel ER; McKenney JK; Thomas M; Roman JJ; Burnett A; Tognon G; Bandiera E; Pecorelli S
Clin Cancer Res; 2007 Jun; 13(11):3339-46. PubMed ID: 17545541
[TBL] [Abstract][Full Text] [Related]
17. Expression of Clostridium perfringens enterotoxin receptors claudin-3 and claudin-4 in prostate cancer epithelium.
Long H; Crean CD; Lee WH; Cummings OW; Gabig TG
Cancer Res; 2001 Nov; 61(21):7878-81. PubMed ID: 11691807
[TBL] [Abstract][Full Text] [Related]
18. HDAC gene expression in pancreatic tumor cell lines following treatment with the HDAC inhibitors panobinostat (LBH589) and trichostatine (TSA).
Mehdi O; Françoise S; Sofia CL; Urs G; Kevin Z; Bernard S; Igor S; Anabela CD; Dominique L; Eric M; Ali O
Pancreatology; 2012; 12(2):146-55. PubMed ID: 22487525
[TBL] [Abstract][Full Text] [Related]
19. Claudin-4-targeting of diphtheria toxin fragment A using a C-terminal fragment of Clostridium perfringens enterotoxin.
Kakutani H; Kondoh M; Saeki R; Fujii M; Watanabe Y; Mizuguchi H; Yagi K
Eur J Pharm Biopharm; 2010 Jun; 75(2):213-7. PubMed ID: 20226859
[TBL] [Abstract][Full Text] [Related]
20. Claudin-4 expression predicts survival in pancreatic ductal adenocarcinoma.
Tsutsumi K; Sato N; Tanabe R; Mizumoto K; Morimatsu K; Kayashima T; Fujita H; Ohuchida K; Ohtsuka T; Takahata S; Nakamura M; Tanaka M
Ann Surg Oncol; 2012 Jul; 19 Suppl 3():S491-9. PubMed ID: 21837532
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]